Clarithromycin transport by gingival fibroblasts and epithelial cells

Journal of Dental Research

Volumn 87, Issue 8, 2008, Pages 777-781

  Chou, C H ^a   Walters, J D ^a  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

Aggressive periodontitis; Antimicrobial chemotherapy; Macrolides

Indexed keywords

ANTIINFECTIVE AGENT; CLARITHROMYCIN;

ARTICLE; CYTOLOGY; EPITHELIUM CELL; FIBROBLAST; GINGIVA; HUMAN; METABOLISM; SQUAMOUS CELL CARCINOMA; TONGUE TUMOR; TUMOR CELL LINE;

ANTI-BACTERIAL AGENTS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CLARITHROMYCIN; EPITHELIAL CELLS; FIBROBLASTS; GINGIVA; HUMANS; TONGUE NEOPLASMS;

EID: 51249088947     PISSN: 00220345     EISSN: None     Source Type: Journal    
DOI: 10.1177/154405910808700812     Document Type: Article

References (32)

1. Blandizzi C, Malizia T, Lupetti A, Pesce D, Gabriele M, Giuca MR, et al. (1999). Periodontal tissue disposition of azithromycin in patients affected by chronic inflammatory periodontal diseases. J Periodontol 70:960-966.
2. Bosnar M, Kelneric Z, Munic V, Erakovic V, Parnham MJ (2005). Cellular uptake and efflux of azithromycin, erythromycin, clarithromycin, telithromycin, and cethromycin. Antimicrob Agents Chemother 49:2372-2377.
3. Bragd L, Dahlén G, Wikström M, Slots J (1987). The capability of Actinobacillus actinomycetemcomitans, Bacteroides gingivalis and Bacteroides intermedius to indicate progressive periodontitis; a retrospective study. J Clin Periodontol 14:95-99.
4. Burrell RC, Walters JD (2008). Distribution of systemic clarithromycin to gingiva. J Periodontol 10.1902/jop.2008.080013 (publish ahead of print).
5. Chadwick PR, Mellersh AR (1987). The use of a tissue culture model to assess the penetration of antibiotics into epithelial cells. J Antimicrob Chemother 19:211-220.
6. Chen C, Slots J (1993). The current status and future prospects of altering the pathogenic microflora of periodontal disease. Curr Opin Periodontol 1:71-77.
7. Christersson LA, Albini B, Zambon JJ, Wikesjö UM, Genco RJ (1987). Tissue localization of Actinobacillus actinomycetemcomitans in human periodontitis. I. Light, immunofluorescence and electron microscopic studies. J Periodontol 58:529-539.
8. Fives-Taylor P, Meyer D, Mintz K (1995). Characteristics of Actinobacillus actinomycetemcomitans invasion of and adhesion to cultured epithelial cells. Adv Dent Res 9:55-62.
9. Goldstein EJC, Citron DM, Merriam CV, Warren Y, Tyrrell K (1999). Activities of telithromycin (HMR 3647, RU66647) compared to those of erythromycin, azithromycin, clarithromycin, roxithromycin and other antimicrobial agents against unusual anaerobes. Antimicrob Agents Chemother 43:2801-2805.
10. Haffajee AD, Socransky SS, Gunsolley JC (2003). Systemic anti-infective periodontal therapy. A systematic review. Ann Periodontol 8:115-181.
11. Inoue K, Kumakura S, Uchida M, Tsutsui T (2004). Effects of eight antibacterial agents on cell survival and expression of epithelial-cell-or cell-adhesion-related genes in human gingival epithelial cells. J Periodontal Res 39:50-58.
12. Larnont RJ, Chan A, Belton CM, Izutsu KT, Vasel D, Weinberg A (1995). Porphyromonas gingivalis invasion of gingival epithelial cells. Infect Immun 63:3878-3885.
13. Lavda M, Clausnitzer CE, Walters JD (2004). Distribution of systemic ciprofloxacin and doxycycline to gingiva and gingival crevicular fluid. J Periodontol 75:1663-1667.
14. Maizurai N, Tamura Y, Kanai H, Tsutsui T (2002). Quantitative comparison of the cytocidal effect of seven macrolide antibiotics on human periodontal ligament fibroblasts. J Periodontal Res 37:250-254.
15. Malizia T, Tejada MR, Ghelardi E, Senesi S, Gabriele M, Giuca MR, et al. (1997). Periodontal tissue disposition of azithromycin. J Periodontaol 68:1206-1209.
16. Mariotti A, Cochran DL (1990). Characterization of fibroblasts derived from human periodontal ligament and gingiva. J Periodontol 61:103-111.
17. Mascarenhas P, Gapski R, Al-Shammari K, Hill R, Soehren S, Fenno JC, et al. (2005). Clinical response of azithromycin as an adjunct to nonsurgical periodontal therapy in stackers. J Periodontol 76:426-436.
18. Merriam CV, Citron DM, Tyrrell KL, Warren YA, Goldstein EJ (2006). In vitro activity of azithromycin and nine comparator agents against 296 strains of oral anaerobes and 31 strains of Eikenella corrodens. Int J Antimicrob Agents 28:244-248.
19. Moore PA (1999). Dental therapeutic indications for the newer long-acting macrolide antibiotics. J Am Dent Assoc 130:1341-1343.
20. Pajukanta R (1993). In vitro antimicrobial susceptibility of Porphyromonas gingivalis to azithromycin, a novel macrolide. Oral Microbiol Immunol 8:325-326.
21. Pajukanta R, Asikainen S, Saarela M, Alaluusua S, Jousimies-Somer H (1992). In vitro activity of azithromycin compared with that of erythromycin against Actinobacillus actinomycetemcomitans. Antimicrob Agents Chemother 36:1241-1243.
22. Pallasch TJ (1996). Pharmacokinetic principles of antimicrobial therapy. Periodontol 2000 10:5-11.
23. Piccolomini R, Catamo G, Di Bonaventura G (1998). Bacteriostatic and bactericidal in vitro activities of clarithromycin and erythromycin against periodontopathic Actinobacillus actinomycetemcomitans. Antimicrob Agents Chemother 42:3000-3001.
24. Rheinwald JG, Beckett MA (1981). Tumorigenic keratinocyte lines requiring anchorage and fibroblast support cultures from human squamous cell carcinomas. Cancer Res 41:1657-1663.
25. Saglie FR, Smith CT, Newman MG, Carranza FA Jr, Pertuiset JH, Cheng L, et al. (1986). The presence of bacteria in the oral epithelium in periodontal disease. II. Immunohistochemical identification of bacteria. J Periodontol 57:492-500.
26. Schentag JJ, Swanson DJ, Smith IL (1985). Dual individualization: antibiotic dosage calculation from the integration of in vitro pharmacodynamics and in vivo pharmacokinetics. J Antimicrob Chemother 15(Suppl A):47-57.
27. Schroeder HE, Listgarten MA (1997). The gingival tissues: the architecture of periodontal protection. Periodontol 2000 13:91-120.
28. Sefton AM, Maskell JP, Beighton D, Whiley A, Shain H, Foyle D, et al. (1996). Azithromycin in the treatment of periodontal disease. Effect on microbial flora. J Clin Periodontol 23:998-1003.
29. Seithel A, Eberl S, Singer K, Auge D, Heinkele G, Wolf NB, et al. (2007). The influence of macrolide antibiotics on the uptake of organic anions and drugs mediated by OATP1B1 and OATP1B3. Drug Metab Dispos 35:779-786.
30. Smith SR, Foyle DM, Daniels J, Joyston-Bechal S, Smales FC, Sefton A, et al. (2002). A double-blind placebo-controlled trial of azithromycin as an adjunct to non-surgical treatment of periodontitis in adults: clinical results. J Clin Periodontol 29:54-61.
31. van Winkelhoff AJ, Rams TE, Slots J (1996). Systemic antibiotic therapy in periodontics. Periodontol 2000 10:45-78.
32. Walters JD, Zhang F, Nakkula RJ (1999). Mechanisms of fluoroquinolone transport by human neutrophils. Antimicrob Agents Chemother 43:2710-2715.